Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$11.27 - $13.53 $540 - $649
-48 Reduced 0.41%
11,713 $139,000
Q4 2023

Jan 31, 2024

SELL
$8.77 - $10.85 $12,339 - $15,265
-1,407 Reduced 10.68%
11,761 $127,000
Q3 2023

Oct 24, 2023

SELL
$9.59 - $11.35 $3,155 - $3,734
-329 Reduced 2.44%
13,168 $129,000
Q2 2023

Jul 27, 2023

SELL
$9.02 - $10.29 $9,209 - $10,506
-1,021 Reduced 7.03%
13,497 $134,000
Q1 2023

May 03, 2023

BUY
$9.2 - $12.26 $27,894 - $37,172
3,032 Added 26.4%
14,518 $139,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $12,696 - $16,831
-1,456 Reduced 11.25%
11,486 $127,000
Q3 2022

Oct 31, 2022

SELL
$8.48 - $11.13 $4,664 - $6,121
-550 Reduced 4.08%
12,942 $110,000
Q2 2022

Jul 27, 2022

SELL
$9.95 - $12.27 $10,208 - $12,589
-1,026 Reduced 7.07%
13,492 $141,000
Q1 2022

Jun 10, 2022

SELL
$9.81 - $15.4 $1.07 Million - $1.67 Million
-108,681 Reduced 88.22%
14,518 $158,000
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $1.06 Million - $1.66 Million
107,824 Added 701.29%
123,199 $52,000
Q4 2021

Jan 25, 2022

SELL
$12.09 - $14.68 $6,685 - $8,118
-553 Reduced 3.47%
15,375 $208,000
Q3 2021

Oct 26, 2021

BUY
$13.25 - $15.13 $36,821 - $42,046
2,779 Added 21.13%
15,928 $216,000
Q2 2021

Aug 06, 2021

SELL
$12.97 - $16.15 $28,897 - $35,982
-2,228 Reduced 14.49%
13,149 $188,000
Q1 2021

Apr 28, 2021

SELL
$13.59 - $18.54 $14,758 - $20,134
-1,086 Reduced 6.6%
15,377 $215,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $235,420 - $308,516
16,463 New
16,463 $309,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.5B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track J.W. Cole Advisors, Inc. Portfolio

Follow J.W. Cole Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.